Latest News





Jakarta, June 17th, 2022 – PT Kalbe Farma Tbk (Kalbe), through its subsidiary PT Bifarma Adiluhung, has launched the latest genetic testings in Indonesia, called KiddyGENME and PrimeGENME. Both tests can analyze DNA variaties, which are related to children’s growth, and the risks of degenerative diseases, that are generally suffered by people in elderly and productive ages.

“GENME by Kalbe, which has been established since 2017, has proven and maintained its stable existence for being the innovator to provide genetic testing services in order to support personalized lifestyles and activities or study plans in optimizing a person’s quality of life,” as stated by the Director of PT Kalbe Farma Tbk, Sie Djohan.

The NutriGENME testing was conducted in 2017, while the SkinGENME testing was established a year later (2018). In 2022, GENME collaborated with Imagene Labs from Singapore in developing two of the latest genetic testings in Indonesia.

The KiddyGENME test examines complete talents and personalities for children’s growth based on genetics and practical approaches. Meanwhile, the PrimeGENME test can become a solution to predict the aging process and examine the risks of degenerative diseases that can be experienced by elderly people, based on genetics,” according to the General Manager of Kalbe Genomics Business, Julito Siahaan.

Dr. David Klinzing, the Chief Technology Officer (CTO) and General Manager (GM) of Imagene Labs, added, We would like to congratulate Kalbe for being the innovator in the field of health and the precised fitness. This partnership will continue an interesting line for Imagene Labs in providing the leading bioinformatic analysis of the precised health in the global health care market.”

During the launch of KiddyGENME and PrimeGENME, an education in a form of a talkshow about genetic testing was conducted as a hybrid seminar entitled Journey to a better ME. dr. Cindiawaty Pudjiadi, Sp.GK., a Cinical Nutrition Specialist, stated that an individual was unique and could be examined through each of their DNAs.

In less than five years, I have implemented methods of lifestyles, diets, and personalized exercises, using a Nutrigenomic genetic testing, to fulfill the needs of my patients. The results immensely help me and my patients in recommending the perfect lifestyle,” as dr. Cindi revealed.

In addition, according to dr. Reza Nugraha Yulisar, Sp.PD., MARS, an Internal Medicine Specialist, many people have put too much focus in their medication, which is more expensive than preventing a disease. Therefore, the curent solution through a genetic testing can predict and examine a potential risk of degenerative diseases.

We hope that the society could implement this technology in order to fight the degenerative diseases in reaching the elderly age, to create a longer and prosperous life expectancy,” as dr. Reza stated.

On the other hand, Prof. Dr. Seto Mulyadi, M.Si., Psikolog or Kak Seto, a Child Psychologist, stated that there have been many testings of interests and talents that could support the children’s growth, but this once-in-a-lifetime genetic testing by Kalbe Farma is considered a new technology here in Indonesia.

As Kak Seto furtherly stated, As parents, we are truly grateful for this new technology and we hope that this testing can be conducted for the sake of our children’s growth that fulfill the quota, as well as to educate and create the next golden generation of Indonesian children in the future.”

The benefits of the GENME test could be directly obtained by a mompreneur Yovita Lesmana, as she was interested with the test for the sake of her children’s future. Actor Dion Wiyoko has also felt its benefits in providing the best things for his infant child’s growth.

After the GENME test, I have become more organized in maintaining the ideal body type and doing exercises needed for my body. Soon after, the KiddyGENME report will provide me with the necessary knowledge about my children’s future,” as Yovita Lesmana admitted.

As for Dion Wiyoko, I want my child to grow healthy, happy, and to have talents and desire as she wants. Through KiddyGENME and PrimeGENME, I can obtain an insight regarding personalities and behaviours for my child, therefore I can determine the right approach of learning and lifestyle for her.”

The KiddyGENME test covers more than 300 marker genes and provides information about 34 panels of the tendency towards personalities, talents, and eating behaviours, as well as impulsiveness, empathy, repetitive behaviours, sports talent, musical creativity, potentials for obesity, and so on.

KiddyGENME ensures the parents to develop their children’s full potentials in ways that are suitable with their genetic tendencies. Through an arranged planning for their development, parents can also engage in a happier relationship, preventing them from unwanted arguments and coercion into things that are disliked by their children.

Meanwhile, the PrimeGENME genetic testing covers more than 1800 marker genes regarding 34 risks of degenerative diseases, such as the risks for cataract, kidney stones, baldness, decline on cognitive functions, and sleeping disorders. This knowledge provide valuable information on how to plan and personalize the right recommendation of lifestyles, as well as the necessary nutrient intakes to maintain the vitality towards a person’s golden years.

The KiddyGENME and PrimeGENME tests also include interpretations and consultation with an expert. The second benefit, compared with other tests, is that the gene selection based on research has been selected from 8000 scientific papers, multi-ethnical genetic database, and patented bio-informatics.

The tests can only be conducted once in a lifetime and has to be done as early as possible. They are very easy as well since the process only requires saliva with a DNA content from the oral mucosal wall, which will then be stored in a kit that has preservatives.

The test results will be obtained by the Lab around 3 to 4 weeks after the samples are received. All the received genetic testing results will furtherly be consulted by an expert who will provide recommendations of the right lifestyles or activities and studies for patients in order to gain a better quality of life.

Previously, Kalbe had genomic testing services known as NutriGENME and SkinGENME. The NutriGENME test involved the nutrient requirements and the right exercises to support a healthier lifestyle, by examining 79 genes with the total of 12 panels.

On the other hand, the SkinGENME test could predict the tendency for the risk of aging on the skin based on genes, and will later be recommended to a treatment based on such gene condition. With both KiddyGENME and PrimeGENME tests, Kalbe Genetics now has the complete set of services for improving the patients’ quality of life.

The GENME test can be conducted through a home service by contacting the Customer Relation of GENME at 0852-81112343. You can also visit our website at and the Instagram accounts of @kiddygenme and @primegenme to view articles and tips, as well as providing both lifestyle arrangements and the right education based on genes and supporting a healthier and more qualified lifestyle.

For more news about Nutrigenme, kindly check:


Bifarma Adiluhung at a Glance

PT. Bifarma Adiluhung is a subsidiary of Kalbe Farma in the field of biotechnology with the objective of providing biopharmacy generic medicine that are clinically tested and with quality, as well as developing an innovative biopharmaceutical and health examinations that require scientific and clinical developments in the global market. PT. Bifarma Adiluhung is located at the Jakarta Industrial Estate Pulogadung or JIEP in Kalbe Business Innovation Centre Building of the 3rd Floor, Pulogadung Main Street Number 23, Cakung, East Jakarta, the Capital City of Jakarta 13930.

One of its excellent services is a Genetic Biomolecular Testing on health, disease risks, and physical activities, known as NutriGENME. Developed in Indonesia since 2017, NutriGENME is both a pioneer and market leader that has endured in the genetic testing market for health in Indonesia.


Kalbe at a Glance

Founded in 1966, PT Kalbe Farma Tbk (Kalbe) is one of the largest open pharmaceutical companies in Southeast Asia. The company has four main divisions that engage in a portfolio of reliable and diversed brands, such as the prescription medicine division, the health product division which handles free medicines, multivitamins, and ready-to-drink supplement beverages, and the distribution and logistics divisions.

Kalbe has also developed a digital service ecosystem for the society, both in B2B with EMOS and in B2C with KlikDokter. EMOS is an order management application system that facilitates the distribution channels in commencing stock management or supply chain, while KlikDokter is a digital platform for health services, specifically telemedicine, which provides necessary health consultations and products for the society.

Now, Kalbe has more than 40 subsidiaries and 15 production facilities with international standards, employing around 16.000 employees who are being stationed in 76 branches all around Indonesia. Kalbe’s shares has been recorded in the Indonesia Stock Exchange (IDX) since 1991 (IDX:KLBF).



825 Rate this article:
No rating

Please login or register to post comments.